Obesity-induced NAFLD progression is associated with increased systemic and hepatic IL-17A expression [3], however whether IL-17 axis plays a role in other models of NAFLD has not been examined. Here, IL17A is linked to obesity due to melanocortin 4 receptor deficiency.